ResultsIQ

ResultsIQ › Latest results › Lupin Limited

Lupin Limited Q4 FY26 earnings call summary

NSE: LUPIN · BSE: 500257

Earnings call of 8 May 2026, summarised by AI from the filing.

High-single digit revenue growth with around 25% EBITDA margin, factoring Tolvaptan and Mirabegron competition.

Key takeaways

  1. FY27 guidance High-single digit revenue growth with around 25% EBITDA margin, factoring Tolvaptan and Mirabegron competition.
  2. Growth driver US business FY26 sales USD 1,318 million vs USD 944 million, driven by Tolvaptan and Mirabegron.
  3. Main risk Competition for Mirabegron and Tolvaptan expected to impact FY27 margins.

Original filing on BSE

Lupin Limited Q1 FY27 results

As filed: Revenue ₹8,277 cr (+32% year on year), EBITDA ₹2,450 cr (+42% year on year), PAT ₹1,417 cr (+16% year on year), EBITDA margin 29.6% (+203 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹7,475 cr (+32% year on year), EBITDA ₹2,486 cr (+88% year on year), PAT ₹1,469 cr (+88% year on year), EBITDA margin 33.3% (+994 bps). Score 88 of 100, Above trend. Revenue and EBITDA growth were well above the company's own trend; profit growth was above it. EBITDA margin rose 994 bps year on year. Profit rose ₹687 cr on a year ago, more than the ₹414 cr it added the year before. Share price after the results: −7.8% in 29 days (Nifty 500: −3.2%).
  • Q3 FY26: Revenue ₹7,168 cr (+24% year on year), EBITDA ₹2,262 cr (+67% year on year), PAT ₹1,181 cr (+82% year on year), EBITDA margin 31.6% (+807 bps). Score 81 of 100, Above trend. Revenue growth was well above the company's own trend; EBITDA growth was above it; profit before exceptional items growth was in line with it. EBITDA margin rose 807 bps year on year. Consolidated profit +37% but standalone -27%. Profit lagged EBITDA because of depreciation, interest or other income, not the business. Revenue rose ₹1,400 cr on a year ago, more than the ₹571 cr it added the year before. Share price after the results: +8.1% in 30 days (Nifty 500: +0.4%).
  • Q2 FY26: Revenue ₹7,048 cr (+24% year on year), EBITDA ₹2,342 cr (+75% year on year), PAT ₹1,485 cr (+73% year on year), EBITDA margin 33.2% (+959 bps). Score 87 of 100, Above trend. Revenue growth was well above the company's own trend; EBITDA growth was above it; profit growth was below it. EBITDA margin rose 959 bps year on year. Profit rose ₹626 cr on a year ago, more than the ₹364 cr it added the year before. Share price after the results: +7.7% in 30 days (Nifty 500: +0.5%).
  • Q1 FY26: Revenue ₹6,268 cr (+12% year on year), EBITDA ₹1,728 cr (+39% year on year), PAT ₹1,221 cr (+51% year on year), EBITDA margin 27.6% (+541 bps). Score 49 of 100, In line with trend. Revenue, EBITDA and profit growth were below the company's own trend. EBITDA margin rose 541 bps year on year. Tax rate 14%. Revenue rose ₹668 cr on a year ago, against ₹786 cr the year before. Share price after the results: +1.2% in 28 days (Nifty 500: −0.1%).
  • Q4 FY25: Revenue ₹5,667 cr (+14% year on year), EBITDA ₹1,321 cr (+33% year on year), PAT ₹782 cr (+113% year on year), EBITDA margin 23.3% (+321 bps). Score 54 of 100, In line with trend. Revenue and profit growth were in line with the company's own trend; EBITDA growth was below it. EBITDA margin rose 321 bps year on year. Tax rate 13%. Profit fell 9% from last quarter. Revenue rose ₹706 cr on a year ago, more than the ₹531 cr it added the year before. Share price after the results: −3.5% in 30 days (Nifty 500: +1.8%).
  • Q3 FY25: Revenue ₹5,768 cr (+11% year on year), EBITDA ₹1,355 cr (+31% year on year), PAT ₹859 cr (+39% year on year), EBITDA margin 23.5% (+352 bps). Score 30 of 100, Below trend. Revenue and profit growth were below the company's own trend; EBITDA growth was well below it. EBITDA margin rose 352 bps year on year. Revenue rose ₹571 cr on a year ago, against ₹875 cr the year before.
  • Q2 FY25: Revenue ₹5,673 cr (+13% year on year), EBITDA ₹1,341 cr (+46% year on year), PAT ₹859 cr (+74% year on year), EBITDA margin 23.6% (+540 bps). Score 81 of 100, Above trend. EBITDA margin rose 540 bps year on year. Not enough history for a trend yet: scored on growth alone.

Past price moves after results do not indicate future moves. Not a recommendation.

Lupin Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.